Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/28/2008CA2590603A1 Treatment of tardive dyskinesia with pyridoxal 5'-phosphate
11/28/2008CA2590104A1 Method of reducing side effects of isoniazid
11/27/2008WO2008144773A1 New method for preparing isofagomine and its derivatives
11/27/2008WO2008144767A1 Heterocyclic kinase modulators
11/27/2008WO2008144764A1 Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
11/27/2008WO2008144748A1 Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
11/27/2008WO2008144730A2 Stable pharmaceutical formulation for a dpp-iv inhibitor
11/27/2008WO2008144665A1 Use of pimavanserin in the treatment of parkinson and symptoms thereof
11/27/2008WO2008144623A1 Cyclic lactams for the treatment of glaucoma or elevated intraocular pressure
11/27/2008WO2008144604A1 Substituted 2-methyl-2-phenoxy-n-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/27/2008WO2008144602A1 Deuterated zamifenacin derivatives
11/27/2008WO2008144543A2 Compositions and methods for establishing and/or maintaining pregnancy
11/27/2008WO2008144507A2 Spirooxindole inhibitors of aurora kinase
11/27/2008WO2008144500A2 1-methyl-benzo[1,2,4]thiadiazine, 1-oxide derivatives
11/27/2008WO2008144475A1 Methods and compositions for treating cancer
11/27/2008WO2008144464A1 Quinoline derivatives as p13 kinase inhibitors
11/27/2008WO2008144463A1 Quinoline derivatives as pi3 kinase inhibitors
11/27/2008WO2008144458A1 Dissolution of arterial cholesterol plaques by pharmacologically induced elevation of endogenous bile salts
11/27/2008WO2008144455A1 Methods of identifying genes involved in memory formation using small interfering rna(sirna)
11/27/2008WO2008144453A1 Methods of treating cognitive disorders by inhibition of gpr12
11/27/2008WO2008144441A1 Protection of ocular gland tissue and function from adverse external or intrinsic effects in dry eye disorders
11/27/2008WO2008144423A2 Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer
11/27/2008WO2008144399A1 COMPLEXES COMPRISING α2-ADRENERGIC RECEPTOR AGONISTS AND COMPOSITIONS
11/27/2008WO2008144394A2 Fused-ring heterocycle opioids
11/27/2008WO2008144380A1 Hepatitis c virus inhibitors
11/27/2008WO2008144360A1 Novel compounds as cannabinoid receptor ligands
11/27/2008WO2008144352A1 Threitol phosphates, salts thereof and methods of use
11/27/2008WO2008144347A1 Combinations comprising a fluoroquinolone for treating, reducing, ameliorating, or preventing infections
11/27/2008WO2008144346A2 Crystal structures of sglt2 inhibitors and processes for their preparation
11/27/2008WO2008144305A1 Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators
11/27/2008WO2008144299A1 5- (aminoazacyclyl) -3-sulfonyl-lh- indazoles as 5-hydroxytryptamine- 6 ligands for the treatment of cns disorders
11/27/2008WO2008144269A2 Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival
11/27/2008WO2008144268A1 Urotensin ii receptor antagonists
11/27/2008WO2008144266A1 Spiroindalones
11/27/2008WO2008144263A1 Potent indole-3-carbinol-derived antitumor agents
11/27/2008WO2008144253A1 Protein kinase inhibitors and methods for using thereof
11/27/2008WO2008144248A1 Furanone copolymers
11/27/2008WO2008144247A1 Antimicrobial materials and coatings
11/27/2008WO2008144241A2 Altering pharmacokinetics of pirfenidone therapy
11/27/2008WO2008144223A2 Triazolyl aminopyrimidine compounds
11/27/2008WO2008144222A2 Triazolyl aminopyrimidine compounds
11/27/2008WO2008144143A1 Endometriosis treatment
11/27/2008WO2008144072A1 Dose forms comprising vx- 950 and their dosage regimen
11/27/2008WO2008144065A1 Ophthalmic formulations of amyloid- contrast agents and methods of use thereof
11/27/2008WO2008144062A1 Csf-1r inhibitors, compositions, and methods of use
11/27/2008WO2008144061A2 Novel combinations comprising a phosphodiesterase-5 inhibitor and their use
11/27/2008WO2008144045A1 Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
11/27/2008WO2008144011A1 Compounds and methods for treating or preventing autoimmune diseases
11/27/2008WO2008143963A1 Di-substituted amides for enhancing glutamatergic synaptic responses
11/27/2008WO2008143960A1 Ziprasidone formulations
11/27/2008WO2008143916A2 Prokinetic agent for bowel preparation
11/27/2008WO2008143913A1 Method for treating demyelinating diseases
11/27/2008WO2008143906A2 Hypercompressed particles for controlled release of ophthalmic medications
11/27/2008WO2008143876A2 Agents and assays for modulating neurodegeneration
11/27/2008WO2008143863A1 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
11/27/2008WO2008143856A1 Oxo bridged diazepan orexin receptor antagonists
11/27/2008WO2008143761A1 Sunscreen compositions and methods
11/27/2008WO2008143759A1 Pyrimidinones as casein kinase ii (ck2) modulators
11/27/2008WO2008143730A2 Macrolide compounds and methods of making and using the same
11/27/2008WO2008143729A2 Macrolide compounds and methods of making and using the same
11/27/2008WO2008143706A2 Daa peripheral benzodiazepine receptor ligand for cancer imaging and treatment
11/27/2008WO2008143681A1 Methods for identifying areas of a subject's skin that appear to lack volume
11/27/2008WO2008143680A1 Methods for indentifying areas of a subject's skin that appear to lack volume
11/27/2008WO2008143677A1 Stable solid elsamitrucin salts suitable for pharmaceutical formulations
11/27/2008WO2008143674A1 Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/27/2008WO2008143647A2 Methods of treating viral infection
11/27/2008WO2008143637A2 Compositions and methods for making therapies delivered by viral vectors reversible for safety or allele-specificity
11/27/2008WO2008143633A2 Compounds and methods for treatment of alpha-1 antitrypsin deficiency
11/27/2008WO2008143627A2 Targeted whole genome amplification method for identification of pathogens
11/27/2008WO2008143553A1 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering from diseases caused by the monoaminooxidase excessive activity
11/27/2008WO2008143552A1 Agent, pharmaceutical composition, and method for treating the ethyl alcohol and/or narcotic dependence
11/27/2008WO2008143551A1 Active ingredient of a medicinal agent, a medicinal agent, a pharmaceutical composition and method for treating dementia syndrome patients
11/27/2008WO2008143500A1 Tenofovir disoproxil hemi-fumaric acid co-crystal
11/27/2008WO2008143491A1 Pharmaceutical compositions combining a hydrogenated lipstatin derived agent and a hmg-coa reductase inhibiting agent
11/27/2008WO2008143490A1 Pharmaceutical composition combining an anticonvulsant agent and an antiviral agent
11/27/2008WO2008143489A1 Pharmaceutical composition combining a non-steroidal anti-inflammatory agent and an anticonvulsant agent
11/27/2008WO2008143361A1 A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
11/27/2008WO2008143343A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
11/27/2008WO2008143263A1 1-substituted tetrahydroisoquinoline compound
11/27/2008WO2008143262A1 Heterocyclic compound and use thereof
11/27/2008WO2008143254A1 Pharmaceutical containing pparδ agonist
11/27/2008WO2008143241A1 Method for producing pharmaceutical tablet
11/27/2008WO2008143240A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
11/27/2008WO2008143239A1 Crystalline micropowder particles
11/27/2008WO2008143182A1 Composition containing licorice-derived polyphenol
11/27/2008WO2008143145A1 Skin-moisturizing effect evaluation method, and screening method for moisturizing substance by using the evaluation method
11/27/2008WO2008143137A1 Antiviral agent
11/27/2008WO2008142986A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11 β-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY
11/27/2008WO2008142860A1 Novel sweetener having sugar-like taste and production method and use of the same
11/27/2008WO2008142859A1 Novel spiro-oxindole compound and pharmaceutical containing the same
11/27/2008WO2008142693A2 Regulation of myelination by nectin-like (necl) molecules
11/27/2008WO2008142627A2 Multilayered modified release formulation comprising amoxicillin and clavulanate
11/27/2008WO2008142623A2 Tumor necrosis factor - alpha inhibitors
11/27/2008WO2008142550A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008WO2008142513A2 Phosphate-modified oligonucleotide analogs with immunostimulatory activity
11/27/2008WO2008142463A2 Carbamoyl-cyclohexanes for treating acute mania
11/27/2008WO2008142462A1 (thio) -carbamoyl-cyclohexane derivatives and method for treating schizophrenia
11/27/2008WO2008142461A1 Metabolites of (thio)carbamoyl-cyclohexane derivatives
11/27/2008WO2008142454A1 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
11/27/2008WO2008142445A1 Process for the preparation of form a of tegaserod
1 ... 2973 2974 2975 2976 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 ... 7860